154 related articles for article (PubMed ID: 8428108)
1. Primary ovarian cancer: prospective comparison of contrast-enhanced CT and pre-and postcontrast, fat-suppressed MR imaging, with histologic correlation.
Semelka RC; Lawrence PH; Shoenut JP; Heywood M; Kroeker MA; Lotocki R
J Magn Reson Imaging; 1993; 3(1):99-106. PubMed ID: 8428108
[TBL] [Abstract][Full Text] [Related]
2. Bowel disease: prospective comparison of CT and 1.5-T pre- and postcontrast MR imaging with T1-weighted fat-suppressed and breath-hold FLASH sequences.
Semelka RC; Shoenut JP; Silverman R; Kroeker MA; Yaffe CS; Micflikier AB
J Magn Reson Imaging; 1991; 1(6):625-32. PubMed ID: 1823167
[TBL] [Abstract][Full Text] [Related]
3. Renal cancer staging: comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MR imaging.
Semelka RC; Shoenut JP; Magro CM; Kroeker MA; MacMahon R; Greenberg HM
J Magn Reson Imaging; 1993; 3(4):597-602. PubMed ID: 8347952
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT.
Low RN; Carter WD; Saleh F; Sigeti JS
Radiology; 1995 May; 195(2):391-400. PubMed ID: 7724757
[TBL] [Abstract][Full Text] [Related]
5. Renal lesions: controlled comparison between CT and 1.5-T MR imaging with nonenhanced and gadolinium-enhanced fat-suppressed spin-echo and breath-hold FLASH techniques.
Semelka RC; Shoenut JP; Kroeker MA; MacMahon RG; Greenberg HM
Radiology; 1992 Feb; 182(2):425-30. PubMed ID: 1732961
[TBL] [Abstract][Full Text] [Related]
6. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN; Francis IR
AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic disease: prospective comparison of CT, ERCP, and 1.5-T MR imaging with dynamic gadolinium enhancement and fat suppression.
Semelka RC; Kroeker MA; Shoenut JP; Kroeker R; Yaffe CS; Micflikier AB
Radiology; 1991 Dec; 181(3):785-91. PubMed ID: 1947098
[TBL] [Abstract][Full Text] [Related]
8. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression.
Semelka RC; Cumming MJ; Shoenut JP; Magro CM; Yaffe CS; Kroeker MA; Greenberg HM
Radiology; 1993 Mar; 186(3):799-802. PubMed ID: 8381551
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
Low RN; Barone RM; Lacey C; Sigeti JS; Alzate GD; Sebrechts CP
Radiology; 1997 Aug; 204(2):513-20. PubMed ID: 9240546
[TBL] [Abstract][Full Text] [Related]
10. Rectal carcinoma: prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging.
Okizuka H; Sugimura K; Yoshizako T; Kaji Y; Wada A
J Magn Reson Imaging; 1996; 6(3):465-71. PubMed ID: 8724412
[TBL] [Abstract][Full Text] [Related]
11. Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine.
Semelka RC; Shoenut JP; Lawrence PH; Greenberg HM; Madden TP; Kroeker MA
Radiology; 1992 Nov; 185(2):479-82. PubMed ID: 1410358
[TBL] [Abstract][Full Text] [Related]
12. Solitary hepatic metastasis: comparison of dynamic contrast-enhanced CT and MR imaging with fat-suppressed T2-weighted, breath-hold T1-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences.
Semelka RC; Shoenut JP; Ascher SM; Kroeker MA; Greenberg HM; Yaffe CS; Micflikier AB
J Magn Reson Imaging; 1994; 4(3):319-23. PubMed ID: 8061428
[TBL] [Abstract][Full Text] [Related]
13. Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT.
Tanimoto A; Yuasa Y; Imai Y; Izutsu M; Hiramatsu K; Tachibana M; Tazaki H
Radiology; 1992 Dec; 185(3):741-7. PubMed ID: 1438756
[TBL] [Abstract][Full Text] [Related]
14. Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT.
Yamashita Y; Honda S; Nishiharu T; Urata J; Takahashi M
AJR Am J Roentgenol; 1996 May; 166(5):1151-5. PubMed ID: 8615260
[TBL] [Abstract][Full Text] [Related]
15. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
16. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients.
Kuhn MJ; Hammer GM; Swenson LC; Youssef HT; Gleason TJ
Comput Med Imaging Graph; 1994; 18(5):391-9. PubMed ID: 7954317
[TBL] [Abstract][Full Text] [Related]
17. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging.
Kim B; Semelka RC; Ascher SM; Chalpin DB; Carroll PR; Hricak H
Radiology; 1994 Oct; 193(1):239-45. PubMed ID: 8090898
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced breath-hold MR imaging of thoracic malignancy using cardiac compensation.
Low RN; Sigeti JS; Song SY; Shimakawa A; Pelc NJ
J Magn Reson Imaging; 1996; 6(4):625-31. PubMed ID: 8835956
[TBL] [Abstract][Full Text] [Related]
19. Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T.
Stevens SK; Hricak H; Stern JL
Radiology; 1991 Nov; 181(2):481-8. PubMed ID: 1924792
[TBL] [Abstract][Full Text] [Related]
20. Chronic pancreatitis: MR imaging features before and after administration of gadopentetate dimeglumine.
Semelka RC; Shoenut JP; Kroeker MA; Micflikier AB
J Magn Reson Imaging; 1993; 3(1):79-82. PubMed ID: 8428105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
